Elmar Schnee

Fisons Plc Manufactured and supplied ethical and proprietary medicines, veterinary products, laboratory and educational scientific equipment, clinical diagnostic supplies and garden products. The company was headquartered in Ipswichm the United Kingdom.

Part of Interpublic Group of Cos., Inc., Migliara Kaplan & Associates is a full-service health care marketing company. The company is based in Owings Mills, MD. The company was founded by Joseph M. Migliara, Harris Kaplan. Migliara Kaplan & Associates was acquired by NFO Research, Inc. on January 09, 1996 for $15.20 million.

Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France.

Noorik Biopharmaceuticals AG is a Swiss drug development company. The private company is based in Basel, Switzerland.

Clinigen Ltd. engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom.

Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland.

ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom.

UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom.

Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates.

MindMaze SA engages in the development of a neuro-inspired computing platform that captures brain activity upon intent, creating a new operating system for computers. It also engages in the use of virtual reality to rehabilitate the brains of stroke patients. The company was founded by Tej Tadi in 2012 and is headquartered in Lausanne, Switzerland.

Calliditas Therapeutics France SAS is a biopharmaceutical company, which engages in the NOX therapies. Its therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and eurodegeneration. The firm’s platform enables the identification of orally available small molecules that selectively inhibit specific NOX enzymes. The company was founded in 2006 and is headquartered in Saint-Julien-en-Genevois, France.

EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom.

Mindmaze, Inc. operates as a computing platform that captures brain activity. The firm develops medical virtual reality products for neural sicknesses. The firm offers MindMotion PRO, is FDA-cleared to bring 3D virtual environment therapy for neuro rehabilitation to patients. The company was founded by Tej Tadi in 2012 and is headquartered in San Francisco, CA.

Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France.

Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom.